Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici PlcfiledCriticalIci Plc
Priority to NO920034ApriorityCriticalpatent/NO179575C/en
Publication of NO920034D0publicationCriticalpatent/NO920034D0/en
Publication of NO920034LpublicationCriticalpatent/NO920034L/en
Priority to NO960116Aprioritypatent/NO300097B1/en
Publication of NO179575BpublicationCriticalpatent/NO179575B/en
Publication of NO179575CpublicationCriticalpatent/NO179575C/en
NO920034A1992-01-021992-01-02
Pharmaceutical preparation containing a physical form of the compound N- [4- [5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl-3-methoxybenzoyl] -2-methylbenzenesulfonamide
NO179575C
(en)
Pharmaceutical preparation containing a physical form of the compound N- [4- [5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl-3-methoxybenzoyl] -2-methylbenzenesulfonamide
Process for the preparation of a physical form of N- [4- [5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl] -3-methoxybenzoyl | -2-methylbenzenesulfonamide
Pharmaceutical preparation containing a physical form of the compound N- [4- [5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl-3-methoxybenzoyl] -2-methylbenzenesulfonamide
Pharmaceutical preparation containing a physical form of the compound N- [4- [5- (cyclopentyloxycarbonyl) amino-1-methylindol-3-ylmethyl-3-methoxybenzoyl] -2-methylbenzenesulfonamide